STTK Shattuck Labs, Inc.
Price Chart
Executive Summary
Shattuck Labs closed a $75M underwritten public offering of 10.9M common shares and 7.9M pre-funded warrants at $4.00/share, with the underwriters' option for an additional 2.8M shares exercised in full. The offering follows two prior 424B5 filings within the past week and concurrent warrant exercises generating ~$54.9M, extending cash runway into 2029. The substantial dilution to existing shareholders is the dominant event, outweighing the positive cash infusion.
Key Financial Metrics
Actionable Insight
The dilutive overhang from this offering and the concurrent warrant exercises will pressure STTK shares near term. Monitor for any insider selling after the 60-day lock-up expires and for upcoming quarterly results to assess whether the extended cash runway translates into clinical milestones for lead candidate SL-325.
Key Facts
- Underwritten public offering of 10,879,376 common shares and 7,870,624 pre-funded warrants at $4.00/share (common) and $3.9999/warrant
- Underwriters' option for 2,812,500 additional shares exercised in full on June 10, 2026
- Underwriting discount of $0.24/share (purchase price $3.76 vs offering price $4.00)
- Pre-funded warrants exercisable at $0.0001/share with 4.99%/9.99% beneficial ownership limitation
- Offering expected to close June 11, 2026; proceeds extend cash runway into 2029
- Concurrent disclosure that ~96% of August 2025 PIPE warrants exercised, generating ~$54.9M gross proceeds
- 60-day lock-up agreements with executive officers and directors
Financial Impact
~$75M gross proceeds from offering; ~$70.5M net proceeds after underwriting discounts; immediate dilution of ~$2.08/share (52% of offering price) to new investors
Risk Factors
- Immediate and substantial dilution to existing shareholders
- Potential for further dilution if additional capital raises are needed before revenue generation
- Pre-clinical stage company with no approved products; clinical trial risk for SL-325
Market Snapshot
Documents Analyzed
This report is based on 7 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-266745 |
| Document: d163713dex41.htm | 0001193125-26-266745 |
| Document: d163713d8k.htm | 0001193125-26-266745 |
| Document: d163713dex51.htm | 0001193125-26-266745 |
| Document: 0001193125-26-266745-index-headers.html | 0001193125-26-266745 |
| Document: 0001193125-26-266745-index.html | 0001193125-26-266745 |
| Document: 0001193125-26-266745.txt | 0001193125-26-266745 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 11, 2026
7d ago
|
8-K
| $4.18 $4.74 | ▼ −13.40% | ▼ −12.96% | $4.74 (−13.40%) |
|
Jun 11, 2026
7d ago
|
Institutional Cluster
| $4.18 $4.74 | ▼ −13.40% | ▼ −12.96% | $4.74 (−13.40%) |
|
Jun 11, 2026
7d ago
|
424B5
| $4.18 $4.74 | ▼ −13.40% | ▼ −12.96% | $4.74 (−13.40%) |
|
Jun 10, 2026
9d ago
|
Press Release
| $4.13 $4.33 | ▼ −4.84% | ▼ −1.41% | $4.74 (−14.77%) |
|
Jun 9, 2026
9d ago
|
424B5
| $4.13 $4.33 | ▼ −4.84% | ▼ −1.41% | $4.74 (−14.77%) |
|
Jun 9, 2026
9d ago
|
8-K
| $4.13 $4.33 | ▲ +4.84% | ▲ +1.41% | $4.74 (+14.77%) |
|
Jun 2, 2026
16d ago
|
8-K
| $4.75 $4.13 | ▼ −13.05% | ▼ −9.23% | $4.74 (−0.21%) |
|
May 15, 2026
5w ago
|
Insider Cluster
| $6.26 $6.10 | ▼ −2.56% | ▼ −3.52% | $4.74 (−24.28%) |
|
May 12, 2026
5w ago
|
Insider Cluster
| $6.62 $5.79 | ▼ −12.54% | ▼ −11.94% | $4.74 (−28.40%) |
|
May 7, 2026
6w ago
|
8-K
| $6.26 $6.75 | ▲ +7.83% | ▲ +6.32% | $4.74 (−24.28%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access